Anthony Gill

Professor Anthony Gill AM is Professor of Surgical Pathology at the University of Sydney and a senior staff specialist in anatomical pathology at the Royal North Shore Hospital in Sydney. He serves as chairman of the Australian Pancreatic Genome Initiative (APGI) and is a standing editorial board member of the WHO/IARC classification of tumours, the peak international body in surgical pathology. With credentials including MBBS, MD, and FRCPA, Professor Gill has established himself as a leading figure in cancer research and diagnostic pathology.

Professor Gill's research focuses on hereditary cancer syndromes, endocrine pathology, and gastrointestinal pathology with special emphasis on pancreaticobiliary pathology. His work bridges basic science discoveries with clinical applications, developing validated diagnostic tests used worldwide. He has translated numerous advances in cancer knowledge into clinically useful diagnostic tools, particularly in biomarker development and companion diagnostic testing for targeted therapies.

His extensive publication record includes over 500 highly cited original research papers, numerous review articles, and book chapters. The most recent publications demonstrate his leadership in pancreatic cancer research, molecular pathology, and diagnostic criteria development across multiple organ systems. His work spans AI applications in pathology, spatial transcriptomics, multi-omic analyses, and molecular profiling of various cancers.

• Appointed Member of the Order of Australia (AM) in 2018 for service to medical research
• Recipient of the Distinguished Pathologist Award from the International Academy of Pathologists
• Multiple NSW Cancer Institute Wildfire Awards for high-impact publications
• NSW Premier's Award for Excellence in Translational Cancer Research
• Benjamin Castleman Award from USCAP for outstanding pathology research

Professor Gill is deeply committed to education, serving as lead for clinical pathology teaching at the University of Sydney. He has received multiple teaching awards including the Northern Clinical School Students Choice award for best lecturer. His professional leadership extends to numerous prestigious appointments including President of the International Endocrine Pathology Society (2019-2020), Founding President of the Australasian Gastrointestinal Pathology Society, and Series champion for the International Collaboration on Cancer Reporting.

His laboratory work and research group, the Cancer Diagnosis and Pathology Research Group, focuses on translating molecular discoveries into clinical diagnostic applications. The group maintains strong international collaborations, particularly through the Australian Pancreatic Genome Initiative and WHO/IARC working groups, driving innovation in cancer diagnosis and treatment worldwide.